Udaya S Tantry - JoVE Visualize

Showing results (211-220 of 227) with videos related to

Pageof 23

Sort By:

Nature Biomedical Engineering|October 30, 2020

Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substratesTiancheng Liu, Jessica Hsiung, Su Zhao, et al.

European Heart Journal|March 1, 2023

Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarctionSeung Hun Lee, Hyun Kuk Kim, Jong-Hwa Ahn, et al.

Nature Reviews. Cardiology|January 14, 2022

Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers ColloquiumDiana A Gorog, Robert F Storey, Paul A Gurbel, et al.

JAMA|November 3, 2012

Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudyPaul A Gurbel, David Erlinge, E Magnus Ohman, et al.

Critical Care Explorations|March 13, 2023

Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild CasesDaisuke Katagiri, Yusuke Asai, Norio Ohmagari, et al.

Journal of the American College of Cardiology|September 11, 2010

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphateLaurent Bonello, Udaya S Tantry, Rossella Marcucci, et al.

Thrombosis and Haemostasis|January 5, 2021

Pharmacodynamic Profile and Prevalence of Bleeding Episode in East Asian Patients with Acute Coronary Syndromes Treated with Prasugrel Standard-Dose versus De-escalation Strategy: A Randomized A-MATCH TrialYoung-Hoon Jeong, Ju-Hyeon Oh, Hyuck-Jun Yoon, et al.

European Heart Journal|April 22, 2015

Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary interventionDániel Aradi, Ajay Kirtane, Laurent Bonello, et al.

Advances in Therapy|June 4, 2021

Platelet Reactivity and Coagulation Markers in Patients with COVID-19Adriadne J Bertolin, Talia F Dalçóquio, Rocío Salsoso, et al.

Circulation|November 1, 2017

International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting TherapiesDominick J Angiolillo, Fabiana Rollini, Robert F Storey, et al.

Pageof 23

Showing results (211-220 of 227) with videos related to

Sort By:

Pageof 23

Nature Biomedical Engineering|October 30, 2020

Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substratesTiancheng Liu, Jessica Hsiung, Su Zhao, et al.

European Heart Journal|March 1, 2023

Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarctionSeung Hun Lee, Hyun Kuk Kim, Jong-Hwa Ahn, et al.

Nature Reviews. Cardiology|January 14, 2022

Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers ColloquiumDiana A Gorog, Robert F Storey, Paul A Gurbel, et al.

JAMA|November 3, 2012

Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudyPaul A Gurbel, David Erlinge, E Magnus Ohman, et al.

Critical Care Explorations|March 13, 2023

Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild CasesDaisuke Katagiri, Yusuke Asai, Norio Ohmagari, et al.

Journal of the American College of Cardiology|September 11, 2010

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphateLaurent Bonello, Udaya S Tantry, Rossella Marcucci, et al.

Thrombosis and Haemostasis|January 5, 2021

Pharmacodynamic Profile and Prevalence of Bleeding Episode in East Asian Patients with Acute Coronary Syndromes Treated with Prasugrel Standard-Dose versus De-escalation Strategy: A Randomized A-MATCH TrialYoung-Hoon Jeong, Ju-Hyeon Oh, Hyuck-Jun Yoon, et al.

European Heart Journal|April 22, 2015

Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary interventionDániel Aradi, Ajay Kirtane, Laurent Bonello, et al.

Advances in Therapy|June 4, 2021

Platelet Reactivity and Coagulation Markers in Patients with COVID-19Adriadne J Bertolin, Talia F Dalçóquio, Rocío Salsoso, et al.

Circulation|November 1, 2017

International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting TherapiesDominick J Angiolillo, Fabiana Rollini, Robert F Storey, et al.

Pageof 23